The Beginning of the road
Nanoimmunotech is born from the cooperation of the Biomedical Research Center (CINBIO) of Vigo and the Nanoscience Institute of Aragón (INA) within a CONSOLIDER project called NANOBIOMED.
Awards and R&D
Best Biotechnological Business Project of the year (Genoma España).
Bancaja Young Entrepreneurship Award.
NEOTEC financing granted by the Centre for the Development of Industrial Technology (CDTI), a Spanish public organization, under the Ministry of Science and Innovation.
Our R&D team intensively works in optimizing the protocols regarding characterization and bioconjugation (functionalization).
Funding and first customer
First funding round:
More than 1 million euros (public and private).
We start offering biofunctionalization and characterization services.
NEW IMAGE AND NEW PROJECTS
COLIVAC R&D project
(FEDER-INNTERCONECTA National R&D project): E. coli nanovaccine using its nanoimmunotech bioconjugation technology.
HELLOKIT R&D project:
New drug delivery platform for the development of new cancer therapies, using nanoparticles for magnetic hyperthermia technique.
New products New laboratory
New business area
Dedicated to the production and distribution of nanoparticles.
NANOIMMUNOTECH new headquarters in Vigo:
New facilities in the CITEXVI prestigious building, counting with a wide laboratory of about 100 m2 with top-notch equipment.
ACACIA R&D project:
Biosensors to detect different analytes such as antibiotics or pesticides.
INNOVASABOR R&D project:
Development of new industrial technology and nanotechnology for the production of pork products.
Starting in the biosensors field
Technology is born.
NAREB R&D project:
Optimization of nanoformulations of antibacterial therapeutics in order to improve the therapy of multi-drug resistant tuberculosis and MRSA infections.
Distributors network in different countries.
Projects and more projects
New projects using heatsens technology for main food pathogens and allergens
HEATSENS_S SME instrument (phase 1):
New project for the detection of Salmonella typhimurium in chicken meat using Heatsens technology.
ALISEG R&D project:
HEATSENS for E. Coli and C. jejuni identification.
SF4SF R&D project:
HEATSENS for Gluten and L. monocytogenes identification.
European projects focused on nanosafety
Bioactive implantable capsule for pancreatic islets immunosuppression free therapy.
Novel sustainable marine bio-surfactant/ bio-emulsifiers for commercial exploitation.
Our customers are present in more than 25 countries
HEATSENS ALMOST A REALITY
We move our laboratory in Zaragoza to a new location leaving behind the business incubator.
HEATSENS_S SME instrument (phase2):
European commission will co-finance HEATSENS_S development.
SENSO3 R&D project:
Elimination of pollutants from urban wastewater through ozonation controlled by biosensors.
HEATSENS is here!
Exploring new formats for HEATSENS technology commercialization
HEATSENS will be available in three different formats for diverse customer needs:
HEATSENS® 1100 Microfluidic Strip Reader
HEATSENS® 8100 Microfluidic Platform
HEATSENS® 9600 Thermal ISA Platform
Firsts stages for obtaining ISO 9001 (Quality management) and ISO 16140 (Microbiology of the food chain - Protocol for the validation of alternative methods against a reference method) acredditations.
NEW DEAL R&D Project
New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinase 3.